Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Medpace (MEDP). But which of these two companies is the best option for those
The latest trading day saw Medpace (MEDP) settling at $443, representing a +1.84% change from its previous close.

Medpace (MEDP) Upgraded to Strong Buy: Here's Why

01:02pm, Thursday, 11'th Jul 2024
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
In the latest trading session, Medpace (MEDP) closed at $405.33, marking a -0.53% move from the previous day.
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2024 financial results after the market close on Monday, July
Medpace (MEDP) closed the most recent trading day at $395.95, moving +0.52% from the previous trading session.
The latest trading day saw Medpace (MEDP) settling at $405.68, representing a +1.12% change from its previous close.
Wall Street's popular adages are not matching this year. April is historically known for being favorable to investors. But this year, April ended on a disappointing note. For May, the popular adage is
We have narrowed our search to five growth stocks that have solid upside left for 2024. These stocks are: APP, DDOG, MNDY, MEDP, WING.
We have selected five services-oriented stocks that have strong potential for the rest of 2024. These stocks are: MEDP, TXRH, WING, GS, RGA.
Five Nasdaq listed non-tech stocks that have provided more than 40% returns year to date and have more potential for growth. These are: COIN, MEDP, WING, TXRH, TSCO.
Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms. Medpace stands out among its p
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The latest trading day saw Medpace (MEDP) settling at $390.81, representing a +0.07% change from its previous close.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE